Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells.

Maclean GA, Menne TF, Guo G, Sanchez DJ, Park IH, Daley GQ, Orkin SH.

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17567-72. doi: 10.1073/pnas.1215468109. Epub 2012 Oct 8.

2.

Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells.

Chou ST, Byrska-Bishop M, Tober JM, Yao Y, Vandorn D, Opalinska JB, Mills JA, Choi JK, Speck NA, Gadue P, Hardison RC, Nemiroff RL, French DL, Weiss MJ.

Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17573-8. doi: 10.1073/pnas.1211175109. Epub 2012 Oct 8.

3.

Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.

Vaziri H, Chapman KB, Guigova A, Teichroeb J, Lacher MD, Sternberg H, Singec I, Briggs L, Wheeler J, Sampathkumar J, Gonzalez R, Larocca D, Murai J, Snyder E, Andrews WH, Funk WD, West MD.

Regen Med. 2010 May;5(3):345-63. doi: 10.2217/rme.10.21.

PMID:
20230312
4.

Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.

Mali P, Ye Z, Hommond HH, Yu X, Lin J, Chen G, Zou J, Cheng L.

Stem Cells. 2008 Aug;26(8):1998-2005. doi: 10.1634/stemcells.2008-0346. Epub 2008 May 29.

5.

Hematopoietic development from human induced pluripotent stem cells.

Lengerke C, Grauer M, Niebuhr NI, Riedt T, Kanz L, Park IH, Daley GQ.

Ann N Y Acad Sci. 2009 Sep;1176:219-27. doi: 10.1111/j.1749-6632.2009.04606.x.

6.

Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.

Hoeller S, Bihl MP, Tzankov A, Chaffard R, Hirschmann P, Miny P, Kühne T, Bruder E.

Hum Pathol. 2014 May;45(5):1003-9. doi: 10.1016/j.humpath.2013.12.014. Epub 2014 Jan 17.

PMID:
24746204
7.

The impact of trisomy 21 on foetal haematopoiesis.

Roberts I, O'Connor D, Roy A, Cowan G, Vyas P.

Blood Cells Mol Dis. 2013 Dec;51(4):277-81. doi: 10.1016/j.bcmd.2013.07.008. Epub 2013 Aug 7. Review.

8.
9.

Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21.

Gonzales PK, Roberts CM, Fonte V, Jacobsen C, Stein GH, Link CD.

PLoS One. 2018 Mar 27;13(3):e0194581. doi: 10.1371/journal.pone.0194581. eCollection 2018.

10.

Trisomy correction in Down syndrome induced pluripotent stem cells.

Li LB, Chang KH, Wang PR, Hirata RK, Papayannopoulou T, Russell DW.

Cell Stem Cell. 2012 Nov 2;11(5):615-9. doi: 10.1016/j.stem.2012.08.004. Epub 2012 Oct 18.

11.

Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro.

Chiang JC, Jiang J, Newburger PE, Lawrence JB.

Nat Commun. 2018 Dec 5;9(1):5180. doi: 10.1038/s41467-018-07630-y.

12.

Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.

Niwa A, Umeda K, Chang H, Saito M, Okita K, Takahashi K, Nakagawa M, Yamanaka S, Nakahata T, Heike T.

J Cell Physiol. 2009 Nov;221(2):367-77. doi: 10.1002/jcp.21864.

PMID:
19562687
13.

Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.

Chicha L, Feki A, Boni A, Irion O, Hovatta O, Jaconi M.

PLoS One. 2011 Feb 25;6(2):e14733. doi: 10.1371/journal.pone.0014733.

14.

Trisomy 21 enhances human fetal erythro-megakaryocytic development.

Chou ST, Opalinska JB, Yao Y, Fernandes MA, Kalota A, Brooks JS, Choi JK, Gewirtz AM, Danet-Desnoyers GA, Nemiroff RL, Weiss MJ.

Blood. 2008 Dec 1;112(12):4503-6. doi: 10.1182/blood-2008-05-157859. Epub 2008 Sep 23.

15.

Hematopoiesis from pluripotent stem cell lines.

Sakamoto H, Tsuji-Tamura K, Ogawa M.

Int J Hematol. 2010 Apr;91(3):384-91. doi: 10.1007/s12185-010-0519-7. Epub 2010 Feb 20. Review.

PMID:
20169427
16.

T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures.

Kennedy M, Awong G, Sturgeon CM, Ditadi A, LaMotte-Mohs R, Zúñiga-Pflücker JC, Keller G.

Cell Rep. 2012 Dec 27;2(6):1722-35. doi: 10.1016/j.celrep.2012.11.003. Epub 2012 Dec 7.

17.

Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin.

Chang KH, Nelson AM, Cao H, Wang L, Nakamoto B, Ware CB, Papayannopoulou T.

Blood. 2006 Sep 1;108(5):1515-23. Epub 2006 Apr 27.

18.

Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells.

Bardy J, Chen AK, Lim YM, Wu S, Wei S, Weiping H, Chan K, Reuveny S, Oh SK.

Tissue Eng Part C Methods. 2013 Feb;19(2):166-80. doi: 10.1089/ten.TEC.2012.0146. Epub 2012 Sep 4.

PMID:
22834957
19.

Derivation, characterization, and differentiation of human embryonic stem cells.

Heins N, Englund MC, Sjöblom C, Dahl U, Tonning A, Bergh C, Lindahl A, Hanson C, Semb H.

Stem Cells. 2004;22(3):367-76.

20.

Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells.

Irion S, Clarke RL, Luche H, Kim I, Morrison SJ, Fehling HJ, Keller GM.

Development. 2010 Sep 1;137(17):2829-39. doi: 10.1242/dev.042119. Epub 2010 Jul 21.

Supplemental Content

Support Center